Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus - Takeaways - MDSpire

Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus

  • By

  • Sanjiv Kandhari

  • Jayakar Thomas

  • Niti Khunger

  • Maya Vedamurthy

  • Kiran Godse

  • Abir Saraswat

  • Nina Madnani

  • Vijay Somani

  • Sushil Tahiliani

  • Bela Shah

  • C. R. Srinivas

  • Asit Mittal

  • Mukesh Girdhar

  • Maleeka Sachdeva

  • Sachin Varma

  • Manjunath Shenoy

  • Shyamanta Barua

  • Abhishek De

  • Akshay Jain

  • Aseem Sharma

  • March 31, 2026

  • 0 min

Share

  • 1

    The ERAISE ACNE consensus provides guidelines for isotretinoin use in severe acne cases, emphasizing early intervention after first-line therapy failure.

  • 2

    Conventional dosing of isotretinoin (0.5–1 mg/kg/day) is recommended for severe acne, while low-dose regimens are suitable for moderate cases.

  • 3

    Risk-adapted laboratory monitoring is preferred over universal approaches, acknowledging potential adverse effects and contraindications of isotretinoin.

  • 4

    Procedures like comedone extraction and chemical peels are endorsed during isotretinoin therapy for appropriate candidates.

  • 5

    The consensus aims to standardize isotretinoin use in India, addressing regional differences and enhancing acne management strategies.

Original Source(s)

Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus

  • by Sanjiv Kandhari, Jayakar Thomas, Niti Khunger, Maya Vedamurthy, Kiran Godse, Abir Saraswat, Nina Madnani, Vijay Somani, Sushil Tahiliani, Bela Shah, C. R. Srinivas, Asit Mittal, Mukesh Girdhar, Maleeka Sachdeva, Sachin Varma, Manjunath Shenoy, Shyamanta Barua, Abhishek De, Akshay Jain, Aseem Sharma

  • March 31, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Efficacy Assessment of Intradermal Stromal Vascular Fraction Injection Compared to Saline Injection for Treating Atrophic Acne Scars: A 10-Week, Prospective, Randomized, Split-Face, Single-Blind Study